Mangoceuticals
MGRX
9 hedge funds and large institutions have $136K invested in Mangoceuticals in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
80% more funds holding
Funds holding: 5 → 9 (+4)
0.01% more ownership
Funds ownership: 0.04% → 0.05% (+0.01%)
18% less capital invested
Capital invested by funds: $166K → $136K (-$30.7K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$58.9K |
| 2 |
VCWA
Vanguard Capital Wealth Advisors
Denver,
Colorado
|
+$31.2K |
| 3 |
VF
Virtu Financial
New York
|
+$29.3K |
| 4 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
+$14.1K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$12.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRI
Colonial River Investments
Midlothian,
Virginia
|
-$66.1K |
| 2 |
Two Sigma Investments
New York
|
-$49.6K |
| 3 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
-$19.9K |
| 4 |
PTC
Private Trust Company
Cleveland,
Ohio
|
-$2.75K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$243 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $41.5K | +$58.9K | +3,145 | New |
|
|
DGAM
2
Desjardins Global Asset Management
Montreal,
Quebec, Canada
| $25.1K | +$150 | +8 | New |
|
|
VCWA
3
Vanguard Capital Wealth Advisors
Denver,
Colorado
| $21.3K | +$31.2K | +1,667 | New |
|
|
VF
4
Virtu Financial
New York
| $21K | +$29.3K | +1,565 | New |
|
|
MCG
5
McCollum Christoferson Group
Amherst,
New York
| $9.61K | +$14.1K | +753 | New |
|
|
PAG
6
Private Advisor Group
Morristown,
New Jersey
| $8.68K | +$12.7K | +680 | New |
|
|
IAA
7
Independent Advisor Alliance
Charlotte,
North Carolina
| $8.51K | -$19.9K | -1,066 | -62% |
|
8
Bank of America
Charlotte,
North Carolina
| $102 | +$150 | +8 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $50 | -$243 | -13 | -76% |
|
|
CRI
10
Colonial River Investments
Midlothian,
Virginia
| – | -$66.1K | -2,407 | Closed |
|
|
11
Two Sigma Investments
New York
| – | -$49.6K | -1,807 | Closed |
|
|
PTC
12
Private Trust Company
Cleveland,
Ohio
| – | -$2.75K | -100 | Closed |
|
MGRX Hedge Fund Activity: Q3 2023 in Review
9 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q3 2023, worth a combined $136K — down 18% from $166K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MGRX positions and 3 closed out — a net gain of 4 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $58.9K. The largest seller was Colonial River Investments, exiting entirely with an estimated $66.1K sold.
- 9 institutional investors held Mangoceuticals (MGRX) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $136K of Mangoceuticals stock for Q3 2023, down 18% quarter-over-quarter.
- 7 funds opened new Mangoceuticals positions in Q3 2023 and 3 closed out, a net change of +4 holders.
- The largest Mangoceuticals buyer in Q3 2023 was Citadel Advisors, an estimated $58.9K added.
- The largest Mangoceuticals seller in Q3 2023 was Colonial River Investments, an estimated $66.1K sold.
Based on aggregated 13F filings for Q3 2023.